|
|
|
| Overcoming The Limitations Of CAR T-Cell Therapy | Vittoria Biotherapeutics’ CEO, Nick Siciliano, joins Erin Harris on this episode of Cell & Gene: The Podcast to discuss the company's mission to expand the applications for CAR-based therapeutics by employing novel cell engineering and gene editing technologies. Listen now! |
|
|
|
|
Think real-world data’s only application is clinical trials? Think again. Savvy early-stage biotechs are leveraging RWD in their formative stages, long before entering the clinic, to drive critical efficiencies in drug discovery and development. |
|
|
|
Executives responding to this year’s finance and funding outlook questions are optimistic about the potential for a turnaround in 2024. |
|
|
|
A baker’s dozen of biopharma CEOs answered a call to prioritize and describe challenges they expect to face in the coming year. |
|
|
|
|
| Join The Advancing RNA Community | Introducing Advancing RNA, an online community designed to be a forum and resource for professionals working on RNA-based therapeutics to better understand the challenges that confront them in areas like Analytical/Quality, Manufacturing, Formulation, Outsourcing, Clinical Research, and Supply Chain/Logistics. Sign up for the Advancing RNA newsletter, delivered to your inbox weekly. |
|
|
|
| Delivering Value To Leading Payers | By aligning with payers' strategic priorities, biopharma companies can strengthen their position in the evolving healthcare landscape. Review five key strategic goals driving payer decisions. |
|
|
|
|
|
|
|
Inside you will find more on: - Executive Outlook
- Industry Research
- Retaining Talent
- Supply Chain Outlook
View the digital edition. |
|
|
CONTRIBUTE TO LIFE SCIENCE LEADER |
|
|
|
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director. |
|
|
| Connect With Life Science Leader: |
|
|
|
